Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0001140361-23-029929

Chief Medical Officer sold 4,669 shares at an average $74.22 ($346,516)

  • Chief Medical Officer acquired 4,669 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Garren Hideki Chief Medical Officer 2023-06-14 Option exercise 10b5-1 +4,669 $24.90 $116,258 4,669 D: show line 1 in the form
Garren Hideki Chief Medical Officer 2023-06-14 Sale 10b5-1 −509 $72.45 $36,879 4,160 D: show line 2 in the form
Garren Hideki Chief Medical Officer 2023-06-14 Sale 10b5-1 −971 $73.31 $71,184 3,189 D: show line 3 in the form
Garren Hideki Chief Medical Officer 2023-06-14 Sale 10b5-1 −2,534 $74.59 $189,010 655 D: show line 4 in the form
Garren Hideki Chief Medical Officer 2023-06-14 Sale 10b5-1 −655 $75.49 $49,443 0 D: show line 5 in the form
Open-market sales · 4,669 sh · avg $74.22 · $346,516

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Garren Hideki Chief Medical Officer 2023-06-14 Option exercise · Stock Option (Right to Buy) 10b5-1 −4,669 205,331 D: show line 6 in the form
Loading xslF345X04/form4.xml…